Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults

NCT02431364 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Stopped Administrative reason

Conditions

Healthy

Interventions

DRUG: Verdinexor
OTHER: Placebo

Sponsor

Karyopharm Therapeutics Inc